146 related articles for article (PubMed ID: 2414636)
1. The effect of prednisone in a high-dose, alternate-day regimen on the natural history of idiopathic membranoproliferative glomerulonephritis.
McEnery PT; McAdams AJ; West CD
Medicine (Baltimore); 1985 Nov; 64(6):401-24. PubMed ID: 2414636
[TBL] [Abstract][Full Text] [Related]
2. Differences between membranoproliferative glomerulonephritis types I and III in long-term response to an alternate-day prednisone regimen.
Braun MC; West CD; Strife CF
Am J Kidney Dis; 1999 Dec; 34(6):1022-32. PubMed ID: 10585311
[TBL] [Abstract][Full Text] [Related]
3. Membranoproliferative glomerulonephritis: improved survival with alternate day prednisone therapy.
McEnery PT; McAdams AJ; West CD
Clin Nephrol; 1980 Mar; 13(3):117-24. PubMed ID: 7379361
[TBL] [Abstract][Full Text] [Related]
4. Regression of membranoproliferative glomerulonephritis type II (dense deposit disease): observations in six children.
McEnery PT; McAdams AJ
Am J Kidney Dis; 1988 Aug; 12(2):138-46. PubMed ID: 3400634
[TBL] [Abstract][Full Text] [Related]
5. Response of type I membranoproliferative glomerulonephritis to pulse methylprednisolone and alternate-day prednisone therapy.
Bergstein JM; Andreoli SP
Pediatr Nephrol; 1995 Jun; 9(3):268-71. PubMed ID: 7632508
[TBL] [Abstract][Full Text] [Related]
6. Mesangiocapillary glomerulonephritis: changes in glomerular morphology with long-term alternate-day prednisone therapy.
McAdams AJ; McEnery PT; West CD
J Pediatr; 1975 Jan; 86(1):23-31. PubMed ID: 1089142
[TBL] [Abstract][Full Text] [Related]
7. Membranoproliferative glomerulonephritis and C3 glomerulonephritis: frequency, clinical features, and outcome in children.
Okuda Y; Ishikura K; Hamada R; Harada R; Sakai T; Hamasaki Y; Hataya H; Fukuzawa R; Ogata K; Honda M
Nephrology (Carlton); 2015 Apr; 20(4):286-92. PubMed ID: 25524631
[TBL] [Abstract][Full Text] [Related]
8. Membranoproliferative glomerulonephritis characterized by focal, segmental proliferative lesions.
Strife CF; McAdams AJ; West CD
Clin Nephrol; 1982 Jul; 18(1):9-16. PubMed ID: 6749363
[TBL] [Abstract][Full Text] [Related]
9. Response of crescentic Henoch-Schoenlein purpura nephritis to corticosteroid and azathioprine therapy.
Bergstein J; Leiser J; Andreoli SP
Clin Nephrol; 1998 Jan; 49(1):9-14. PubMed ID: 9491279
[TBL] [Abstract][Full Text] [Related]
10. Dense deposit disease in children: prognostic value of clinical and pathologic indicators. The Southwest Pediatric Nephrology Study Group.
Am J Kidney Dis; 1985 Sep; 6(3):161-9. PubMed ID: 3876030
[TBL] [Abstract][Full Text] [Related]
11. Prednisone therapy of membranoproliferative glomerulonephritis in children.
Warady BA; Guggenheim SJ; Sedman A; Lum GM
J Pediatr; 1985 Nov; 107(5):702-7. PubMed ID: 3903090
[TBL] [Abstract][Full Text] [Related]
12. Immunosuppressive treatment of the nephrotic syndrome due to mesangial lesions.
Faedda R; Pirisi M; Satta A; Tanda F; Bartoli E
Clin Nephrol; 1996 Oct; 46(4):237-44. PubMed ID: 8905208
[TBL] [Abstract][Full Text] [Related]
13. [Serum level and urinary excretion of RANTES in patients with primary glomerulonephritis].
Kacprzyk F
Pol Arch Med Wewn; 2002 Sep; 108(3):837-42. PubMed ID: 12600179
[TBL] [Abstract][Full Text] [Related]
14. [Thin basement membrane disease in patients with asymptomatic hematuria and/or proteinuria: a clinicopathological study].
Ueno M
Nihon Jinzo Gakkai Shi; 1991 Apr; 33(4):339-47. PubMed ID: 1875554
[TBL] [Abstract][Full Text] [Related]
15. [Characteristics of pediatric C3 glomerulopathy with decreased factor H in 3 cases].
He RJ; Xiao HJ; Wang SX; Guan N; Yao Y; Ding J
Zhonghua Er Ke Za Zhi; 2012 Dec; 50(12):939-43. PubMed ID: 23324154
[TBL] [Abstract][Full Text] [Related]
16. Treatment of mesangiocapillary glomerulonephritis with alternate-day prednisone--a report of the International Study of Kidney Disease in Children.
Tarshish P; Bernstein J; Tobin JN; Edelmann CM
Pediatr Nephrol; 1992 Mar; 6(2):123-30. PubMed ID: 1571205
[TBL] [Abstract][Full Text] [Related]
17. Focal segmental membranoproliferative glomerulonephritis in children.
Iitaka K; Nakamura S; Moriya S; Motoyama O; Sakai T
Pediatr Nephrol; 2003 Oct; 18(10):1000-4. PubMed ID: 12883968
[TBL] [Abstract][Full Text] [Related]
18. Treatment of Henoch-Schönlein Purpura glomerulonephritis in children with high-dose corticosteroids plus oral cyclophosphamide.
Flynn JT; Smoyer WE; Bunchman TE; Kershaw DB; Sedman AB
Am J Nephrol; 2001; 21(2):128-33. PubMed ID: 11359020
[TBL] [Abstract][Full Text] [Related]
19. A case of C3 glomerulonephritis successfully treated with eculizumab.
Payette A; Patey N; Dragon-Durey MA; Frémeaux-Bacchi V; Le Deist F; Lapeyraque AL
Pediatr Nephrol; 2015 Jun; 30(6):1033-7. PubMed ID: 25796589
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppressive treatment of membranoproliferative glomerulonephritis.
Faedda R; Satta A; Tanda F; Pirisi M; Bartoli E
Nephron; 1994; 67(1):59-65. PubMed ID: 8052369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
